echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > NMPA approves 2 new class 1 drugs: Hengrui [Hertropopag ethanolamine tablets], Roche [Lisporan oral solution powder]

    NMPA approves 2 new class 1 drugs: Hengrui [Hertropopag ethanolamine tablets], Roche [Lisporan oral solution powder]

    • Last Update: 2021-06-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Just now, NMPA approved the listing of 2 new class 1 drugs: Hengrui [Hertropopag ethanolamine tablets], Roche [Lisporan oral solution powder]


    Herombopag Olamine is a small molecule human thrombopoietin receptor agonist



    Spinal muscular atrophy is an inherited neuromuscular disease caused by a defect in the function of the SMN protein due to a mutation in the survival motor neuron gene 1 (SMN1).


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.